Cite
HARVARD Citation
D'Haens, G. et al. (n.d.). DOP48 Amiselimod, a selective S1P receptor modulator in Crohn's disease patients: a proof-of-concept study. Journal of Crohn's and colitis. pp. S055-S056. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
D'Haens, G. et al. (n.d.). DOP48 Amiselimod, a selective S1P receptor modulator in Crohn's disease patients: a proof-of-concept study. Journal of Crohn's and colitis. pp. S055-S056. [Online].